Graft Polymer (UK) Plc (LSE: GPL) was established in 2017 by a group of polymer technology experts and venture capitalists. Graft Polymer’s core business comprises polymer modification and the development of drug delivery systems. The Group is a highly innovative business with strong intellectual property holding several patent applications. Graft Polymer offers bespoke, adapted, and tailored products for customer requests.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy
